Pralidoxime Chloride (Meridian Medical Technologies, Inc.)
Welcome to the PulseAid listing for the Pralidoxime Chloride drug offered from Meridian Medical Technologies, Inc.. This Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Meridian Medical Technologies, Inc. |
NON-PROPRIETARY NAME: | Pralidoxime Chloride |
SUBSTANCE NAME: | PRALIDOXIME CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1983-04-26 |
END MARKETING DATE: | 0000-00-00 |
Pralidoxime Chloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Pralidoxime Chloride from Meridian Medical Technologies, Inc. |
LABELER NAME: | Meridian Medical Technologies, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 600(mg/2mL) |
START MARKETING DATE: | 1983-04-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 11704-251_3a03ec88-5282-4da2-a5b8-f3320a964e2c |
PRODUCT NDC: | 11704-251 |
APPLICATION NUMBER: | NDA018986 |
Other PRALIDOXIME CHLORIDE Pharmaceutical Manufacturers / Labelers: